top of page
Search

Align Technology: not going down on bad numbers

  • Writer: Abacus Research
    Abacus Research
  • Aug 15, 2022
  • 1 min read

Align is a dental consumer products company that has been struggling in the post Covid world.

  • 2022 downgrades were part of the pandemic dislocation & management’s over-optimism.

  • We believe, ALGN’s business model and competitive position have not been impaired.

  • We see the potential for earnings growth to rebound to 30% over 2022-25 driven by a recovery in revenue growth and operating margins.

  • The multiple is below historical average and low relative to peers, hence why we see 78% upside potential over a couple of years.

Potential Upside: $514 (+78%)

Sensible Downside: $230(-20%)


 
 
 

Recent Posts

See All
Nebius & DigitalOcean: Inference Efficiency

(NBIS, DOCN) 1. The Core AI Thesis At the core of all AI theses there are two beliefs: Demand for intelligence is ~infinite — this still seems to be true, at leas there is no data to the contrary. Com

 
 
 
SEDG, ENPH, NVTS: Plays on 800V

Everybody knows about the 800V conversion that is coming. NVDA etc have released the specs. There are many parts to that ecosystem change. Most of them are not ‘free options’ whereas SEDG and ENPH mos

 
 
 
Axon:

Axon is shifting from selling individual tools to providing an interconnected ecosystem. Hardware like TASERs and cameras now act as "data generators" that feed directly into high-margin software modu

 
 
 

Comments

bottom of page